Professor Ruth Langley is a medical oncologist and MRC Programme Leader based at University College London where she designs and leads oncology clinical trials.
A major focus of her recent work has been the development of an international trial called Add-Aspirin. The trial is looking at whether aspirin could help stop some types of cancer from coming back after treatment as new evidence suggests.
Cancer Research UK states that trials like the Add-Aspirin trial will help researchers work out who is most likely to benefit from taking aspirin, and how best to use it in cancer medicine. Stopping cancer from coming back after treatment is an important challenge, and finding new ways to do so could help to boost long-term survival.
With her keenness to re-purpose existing drugs to treat other disease areas Langley also leads the PATCH trial, which is looking at whether an oestrogen patch designed to alleviate menopausal symptoms in women is also a useful treatment for men with prostate cancer.
Langley has worked in a number of tumour areas including breast, colorectal, and lung cancer. She still maintains sees a small number of cancer patients to keep her research up to date and aligned to changes in clinical practice.Tags: cancer, cancer research, cancer treatment, Women in Science